In particular, its interference with Wnt signaling attenuates in vitro tumor sphere formation and in vivo tumor growth, and reduces the subpopulation of CD133+ CD90+ HCC cells, representing an interesting target for CSC-directed treatment [19]. The gene discussed is THY1; the disease is hepatocellular carcinoma.